At 05:45 a.m. ET, Dow E-minis were up 98 points, or 0.22%, with 7,922 contracts changing hands, S&P 500 E-minis were up 6.25 ...

After the NISAR mission, ISRO is set to launch a 6,500 kg US-based communication satellite, the Block-2 BlueBird (BlueBird 2) ...

Coinbase and MicroStrategy stocks rose as Bitcoin price surged. Shares of Sarepta, Nvidia and AMD were falling in early ...

The word from the FDA is that Prasad has come back at the request of the regulator's Commissioner, Marty Makary, who ...

The ChatGPT o3 model defeated the xAI model Grok 4 in the final round of a chess tournament to find the strongest ...

Prasad resigned from the FDA in July after backlash over his handling of Sarepta’s Elevidys gene therapy, which faced ...

Ukraine and its European allies sought on Sunday to present a united front ahead of a meeting this week between President ...

President Donald Trump announced that he's nominating State Department spokesperson Tammy Bruce to be the next deputy representative of the United States to the United Nations.

T O APPRECIATE the dilemmas the Food and Drug Administration (FDA) faces when it reviews new drugs targeting rare diseases, ...

Dr. Vinay Prasad is back at the FDA less than two weeks after the White House pressed the head of the agency to remove him from his multiple agency leadership roles, an HHS spokesperson said Saturday.

The public deserves to the full story about Dr. Vinay Prasad's temporary resignation and how this might impact regulatory decisions moving forward.

Dr Vinay Prasad, previously ousted from his FDA vaccine chief position due to criticism from Laura Loomer over past ...